Literature DB >> 2300535

High-fat meals increase the clearance of cyclosporine.

S K Gupta1, L Z Benet.   

Abstract

High-fat meals increase the clearance and volume of distribution, but not the mean residence time, of cyclosporine in seven healthy volunteers when either plasma or blood analyses are used. This unexpected finding for a low-extraction ratio drug should not be explainable in terms of increased blood flow. We hypothesize that dietary fat can act as a carrier for cyclosporine and enhance both its volume of distribution and its clearance. We suggest that clearance then occurs following metabolism of lipids due to lipase activity within the hepatocyte, thereby releasing free drug for metabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2300535     DOI: 10.1023/a:1015831408425

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Saturable binding of cyclosporin A to erythrocytes: estimation of binding parameters in renal transplant patients and implications for bioavailability assessment.

Authors:  B Legg; M Rowland
Journal:  Pharm Res       Date:  1988-02       Impact factor: 4.200

2.  The effect of food and cholestyramine on the absorption of cyclosporine in cardiac transplant recipients.

Authors:  A Keogh; R Day; L Critchley; G Duggin; D Baron
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

3.  Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.

Authors:  L S Olanoff; T Walle; T D Cowart; U K Walle; M J Oexmann; E C Conradi
Journal:  Clin Pharmacol Ther       Date:  1986-10       Impact factor: 6.875

4.  In vivo interaction of cyclosporine and Intralipid.

Authors:  R Wassef; Z Cohen; B Langer
Journal:  Transplantation       Date:  1986-02       Impact factor: 4.939

Review 5.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

6.  The effects and side effects of cyclosporine: relationship to drug pharmacokinetics.

Authors:  P A Keown; C R Stiller; A L Laupacis; W Howson; R Coles; M Stawecki; J Koegler; G Carruthers; N McKenzie; N R Sinclair
Journal:  Transplant Proc       Date:  1982-12       Impact factor: 1.066

7.  The effect of food on cyclosporine absorption.

Authors:  R J Ptachcinski; R Venkataramanan; J T Rosenthal; G J Burckart; R J Taylor; T R Hakala
Journal:  Transplantation       Date:  1985-08       Impact factor: 4.939

8.  Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier.

Authors:  W T Cefalu; W M Pardridge
Journal:  J Neurochem       Date:  1985-12       Impact factor: 5.372

9.  Cyclosporine, low-density lipoprotein, and cholesterol.

Authors:  P C de Groen
Journal:  Mayo Clin Proc       Date:  1988-10       Impact factor: 7.616

10.  Metabolism of cyclosporin A. I. Study in freshly isolated rabbit hepatocytes.

Authors:  G Fabre; P Bertault-Peres; I Fabre; P Maurel; S Just; J P Cano
Journal:  Drug Metab Dispos       Date:  1987 May-Jun       Impact factor: 3.922

View more
  20 in total

1.  Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.

Authors:  Yong Song; Wujun Xue; Puxun Tian; Xiaoming Ding; Xiaoming Pan; Hang Yan; Jun Hou; Xinshun Feng; Heli Xiang; Xiaohui Tian; Gaoping Qin; Xiaohu Fan
Journal:  Eur J Clin Pharmacol       Date:  2011-01-29       Impact factor: 2.953

2.  Prediction of acute graft rejection in renal transplantation: the utility of cyclosporine blood concentrations.

Authors:  J Grevel; K L Napoli; M S Welsh; N E Atkinson; B D Kahan
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

Review 3.  Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.

Authors:  Chi-Yuan Wu; Leslie Z Benet
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

4.  Enhancement of the oral absorption of cyclosporin in man.

Authors:  J Drewe; R Meier; J Vonderscher; D Kiss; U Posanski; T Kissel; K Gyr
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

Review 5.  Bioavailability and bioequivalence: focus on physiological factors and variability.

Authors:  Vangelis Karalis; Panos Macheras; Achiel Van Peer; Vinod P Shah
Journal:  Pharm Res       Date:  2008-06-13       Impact factor: 4.200

6.  Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation.

Authors:  E A Mueller; J M Kovarik; J B van Bree; J Grevel; P W Lücker; K Kutz
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

7.  The absorption site of cyclosporin in the human gastrointestinal tract.

Authors:  J Drewe; C Beglinger; T Kissel
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

Review 8.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

Review 9.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 10.  The drug transporter-metabolism alliance: uncovering and defining the interplay.

Authors:  Leslie Z Benet
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.